Lorem ipsum dolor sit amet consectetur elit
Lorem ipsum dolor sit amet consectetur elit
Lorem ipsum dolor sit amet consectetur elit
I'm Julien Willard, a strategy and operations advisor. I bring my economics, strategy, and intelligence background to help you forecast the next bet that blindside your competitors.
Passion for results and bold thinking come together for extraordinary impact. I work with clients who do not hide from the challenges.
.svg){kind=icon}
I will create a business plan covering key areas: defining your audience, setting your product apart, determining costs, planning delivery methods, and building marketing tactics. I will partner with your staff to make sure this plan matches your company goals and identity.
Following rapid audit, I'll build a technology plan that covers software and hardware choices, data management, system integrations. We'll collaborate with your staff to make certain this plan fits your company goals and spending limits.
When you have a project in these areas that needs extra skills or help, I can team up with you and your staff to reach your targets. This might involve creating digital/AI strategy development, running marketing efforts, or product launches.
When you are early in your digital health or biotech business, you don't need a bloated leadership team. At the same time, you need the second-in-charge to help you run the business, interact with investors and payers. You also need someone to be aware of the macroeonomic and policy trends. I can be that for you.
Once I analyze your data, I'll help study market and industry trends to spot possible chances and threats. We'll also examine competitors and rules to help us build practical financial predictions. Read about my detailed offering.
I have lived through over a dozen transactions and know how to prepare for an M&A from operational and technology perspective. My team also helps structure royalty financing deals and find investors.
Together, we will create an international growth plan covering key areas: selecting target countries, setting your product apart, determining costs, planning delivery methods, and building marketing tactics. We'll partner with your staff to make certain this plan matches your company goals and brand.
During strategy planning, we'll assess possible partners and pathways to find ones that fit your products and audience. We'll also study competitors and market patterns to make sure your partner and distribution approach stays strong.
Delivering business value from any transformation program requires significant focus, an appropriate strategy, and understanding of where your saboteurs reside.
I help define the value hypothesis, unit economics, and decision rights. Incentives and reviews align to adoption and business results.
Together, we will select three to five domains that matter for profit, speed, or risk. Write domain charters with target metrics, scale unit, and dependencies. Kill the rest.
I will help map the "point of departure" and "point of arrival" for each domain. Redesign work with AI at the core, not as a layer. Produce new workflows, controls, and handoffs that can scale. You wouldn't remodel your bathroom while the plumbing is crap, would you?
I'll help stand up a small transformation team that enables business-owned solution teams. Run the business and change the business in parallel.
Many U.S. biotech firms are indeed in need of a turnaround in 2025, driven by cash shortages, market instability, and regulatory uncertainty. Yet the sector is still innovating and growing in select areas. Firms prepared to refocus on fundamentals and efficiency are well-positioned to rebound when industry conditions improve.
I partner with former industry operators to quickly install clear decision rights, an interim control tower, and board-ready reporting. Use a CRO-caliber playbook to steady leadership focus and restore stakeholder confidence
I provide hands-on leadership support to control costs through working capital optimization, capital expenditure management, workforce rebalancing, triage vendors, optimize physical structures and their operations.
Together we will build a 13-week cash forecast, manage daily liquidity, and renegotiate terms with creditors and suppliers. Pair it with a restructuring-ready plan and a tight communications cadence.
Many U.S. biotech firms are indeed in need of a turnaround in 2025, driven by cash shortages, market instability, and regulatory uncertainty. Yet the sector is still innovating and growing in select areas. Firms prepared to refocus on fundamentals and efficiency are well-positioned to rebound when industry conditions improve.
I partner with former industry operators to quickly install clear decision rights, an interim control tower, and board-ready reporting. Use a CRO-caliber playbook to steady leadership focus and restore stakeholder confidence
I provide hands-on leadership support to control costs through working capital optimization, capital expenditure management, workforce rebalancing, triage vendors, optimize physical structures and their operations.
Together we will build a 13-week cash forecast, manage daily liquidity, and renegotiate terms with creditors and suppliers. Pair it with a restructuring-ready plan and a tight communications cadence.
Empirical research demonstrates that CEO and executive team composition significantly impacts firm performance. Developing a comprehensive behavioral profile of the executive team prior to PE/VC investment helps ensure your capital is backed by leadership equipped for success. This engagement requires a multi-hour in-person activity.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Julien's deep understanding of the pharmaceutical landscape ensures impactful strategies.
Julien crafts bespoke strategies that align perfectly with your business objectives.
Leverage Julien's insights to navigate challenges and seize opportunities in the market.
Neglecting behavioral factors—such as attitudes, mindsets, resistance to change, and leadership role-modeling—can result in transformation failure, regardless of how well-designed the new processes or structures are. I am trained to profile your people to identify risks and prepare a mitigation plan.
